mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.0068 |
0.8 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.8 |
mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.8 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
-0.033 |
0.8 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.0075 |
0.8 |